Looking for volunteers
Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)
NCT06238713 · Shanghai Changzheng Hospital · Updated 23 July 2026
- What is being tested
- Single-port extraperitoneal robotic-assisted radical prostatectomy with Vattikuti Institute Prostatectomy（VIP） techniques; Multi-port transperitoneal robotic-assisted radical prostatectomy with bilateral intrafascial nerve-sparing techniques
- For
- Prostate Adenocarcinoma; Localized Prostate Carcinoma
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 75 years. About 480 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 8 Jan 2024, ends Dec 2028. Registered 2 Feb 2024.
- Results
- None posted yet.
In the researchers' words
This study is a two-arm, multicenter, randomized controlled clinical trial on whether single-port extraperitoneal VIP RARP is non-inferior to multi-port transperitoneal RARP in terms of functional recovery rate and other key metrics.
Sites
- Changzheng hospitalShanghai, Shanghai Municipality, China